Exciting Times at the PGC roundtable. few observations. Firstly...

Exciting Times at the PGC roundtable. few observations.

Firstly and Frankly Half year report is a bit limping. not the best demonstrate seasonality.
continuous organic growth is not guaranteed.

Secondly, would like to acknowledge the invaluable insight and in-depth balanced info and perspective Joewolf is contributing to us shareholders. thank you

last, as for the Exciting time, Well done Managment for the commitment and passion of Aquisition
(shopping) and pursuing growth and scale, diversity of products, goods, and services in the healthcare sector as well as the ever-growing national footprint.

As mention before Asx 300 is a nice target. i may disagree with the suggested Ebitda multiple of 17 that was mentioned in the presentation this morning. but I can model on PE of x18 after debt reduction. and EBITDA X of 9 to 12.

so following PGC script one can see acquisitions of companies on Editda of 5 to 6 times, amalgamation into the larger group achieving National scale diversity of products, few synergies along the way, few duds hopefully small ones, growing tall enough to be included in the Happy Times of the ASX 300 and hooopa RE valued for Double the purchase price .

and that is the simple winning formula, providing all goes according to script with few hiccups along the way, SP ups, and downs allows for further accumulation as well as few DIV along the way.

A nice thank you to MR Simari will surely follow you up as you move on one day.